Skip to Content

b 861 150 (Flecainide 150 mg)

Pill imprint b 861 150 has been identified as Flecainide acetate 150 mg.

Flecainide is used in the treatment of atrial fibrillation; atrial flutter; supraventricular tachycardia; paroxysmal supraventricular tachycardia; wolff-parkinson-white syndrome (and more), and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Flecainide acetate 150 mg b 861 150
Discount Card Promo
Flecainide acetate
b 861 150
150 mg
14.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
corn starch
sodium stearyl fumarate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.